Experienced med tech investor Lightstone Ventures closes $50M Singapore fund

Lightstone Ventures has invested in several prominent med tech startups including Ardian, Twelve, Zeltiq and Fire1. Now it has closed a $50 million Singapore-focused fund in partnership with Singapore investment company Limited Partners Temasek and EDBI, the corporate investment arm of the Singapore Economic Development Board. LSV has established a subsidiary dubbed Lightstone Singapore to manage the fund. "To be successful, the fund will need to translate ground-breaking technologies currently resident in the prestigious research institutions across Singapore into commercially viable enterprises," Lightstone Singapore CEO Dr. Kenneth Noonan said. "The fund is not only about investing capital, it is about building companies." Release

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.